Skip to content

VACANCY: Data Analyst in Biomarker Discovery

ScaiVision identifies a genomic signature that accurately predicts CAR-T cell therapy efficacy in B-cell lymphoma patients

VACANCY: Data Analyst in Biomarker Discovery

Data Analyst in Biomarker Discovery

Company description:

Scailyte is a globally recognized spin-off from ETH Zürich and pioneer in the field of single-cell data analysis (Nature Spinoff Award, Forbes Top30 in AI, Masschallenge winner, Swiss Top100 Startups). We combine single‐cell technologies and artificial intelligence to make groundbreaking discoveries and develop a new generation of single-cell biomarkers, enabling new avenues in precision medicine. Our approach comprises three key pillars:

  • High-quality biomedical data sets in disease areas with unmet medical need, generated through meticulous project design and execution in collaboration with top clinical researchers.
  • Best-in-class algorithms to extract clinically relevant insights, integrated into an automated data analytics platform for a rapid and scalable workflow.
  • Industrialization of our ultra-sensitive biomarkers through an established and growing network of top clinicians and diagnostics and pharmaceutical companies.

Check out our company video and what our employees say about working at Scailyte: Scailyte Youtube channel.

We are expanding our research portfolio in multiple disease indications and are looking to strengthen our team with a Data Analyst, passionate about making a change for patients, eager to learn and grow professionally, and dedicated to delivering top quality results.

Key responsibilities:

  • Collect, pre-process and gain actionable insights from single cell datasets using our in-house developed single cell AI pipelines.
  • Support the relevant biomedical project drivers by understanding their analytical needs and sharing your findings.
  • Discuss discoveries with the senior data scientist assigned for the project.
  • Automate and maintain our internal sample database

Required qualifications:

  • MSc degree or BSc degree with at least 5 years of experience in a biological or quantitative field (e.g. biology, biomedical sciences, biomedical engineering, physics, mathematics)
  • Experience in examining high throughput biological datasets (e.g. NGS, RNA-seq or CyTOF)
  • Enthusiastic about applying experimental approaches to obtain results
  • Solid knowledge of at least one programming language (e.g. Python or R)
  • Familiarity with the UNIX shell and cloud computing
  • The ability to work in an interdisciplinary/cross-functional environment (e.g. matrix organisation)
  • Excellent written and spoken English

Only candidates with a valid Swiss work permit or EU/ Swiss citizens will be considered.

What we offer:

  • An exciting opportunity to contribute to the growth of a leading startup in the single-cell and precision medicine space, and to work on cutting-edge research projects
  • Work in a collaborative, multi-disciplinary, and international team at the interface of biomedical sciences, data science and medicine
  • Pleasant working environment with great facilities at our office on the Novartis Campus in Basel
  • Permanent employment contract

Application:

Please send your application, including your cover letter and your CV (in English) to careers@scailyte.com or at https://www.linkedin.com/jobs/view/2628529885

Call for applications open until August 1st, 2021

Starting date: October 2021

Recent News

VACANCY: Data Analyst in Biomarker Discovery

We are expanding our research portfolio in multiple disease indications and are looking to strengthe

Read more

Recent News

Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

Scailyte Quarterly Update, June 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

Scailyte announces Michael Brenner, of Harvard Medical School, as an advisor to its Board of Directors

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte announced today that Mich

Read more

Recent News

Scailyte Quarterly Update, April 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

Recent News

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more

Recent News

01 /04

VACANCY: Data Analyst in Biomarker Discovery

We are expanding our research portfolio in multiple disease indications and are looking to strengthe

Read more

Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

02 /04

Scailyte Quarterly Update, June 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Scailyte announces Michael Brenner, of Harvard Medical School, as an advisor to its Board of Directors

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte announced today that Mich

Read more

Recent News

04 /04

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more

Recent News